Why the study?
Intermittent fasting improves neuronal bioenergetics, plasticity, and resilience, but its specific impact across various neurological diseases needed synthesis.
Does intermittent fasting improve symptoms and disease progression in neurological diseases?
Does intermittent fasting improve symptoms and disease progression in neurological diseases?
Intermittent fasting represents a promising, cost-effective metabolic strategy that may complement pharmacological treatments for various neurological disorders.
No takes yet. Share an insight, caveat, or question.
May support intermittent fasting as adjunct in neurological disorders; leaves open confirmation in prospective RCTs.
Jeevitha et al. (2024) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: